Related Experiment Videos
Polycationic lipids translocate lipopolysaccharide into HeLa cells
J R Eldstrom1, K La, D A Mathers
1University of British Columbia, Vancouver, Canada.
Biotechniques
|March 21, 2000
Summary
Researchers used LIPOFECTAMINE to deliver bacterial lipopolysaccharide (LPS) into human cells. This method efficiently loaded cells with LPS, showing low toxicity and enabling intracellular studies of LPS's acute effects.
Area of Science:
- Cell biology
- Molecular biology
- Immunology
Background:
- Lipopolysaccharide (LPS) from E. coli is a potent immune stimulant.
- Investigating intracellular LPS effects requires efficient cellular uptake methods.
- Mammalian cell models are crucial for studying host-pathogen interactions.
Purpose of the Study:
- To evaluate LIPOFECTAMINE's efficacy in translocating E. coli LPS into HeLa cells.
- To assess the intracellular localization and cellular effects of LPS.
- To determine the acute toxicity of LPS loading using this method.
Main Methods:
- Co-incubation of HeLa cells with fluorescein isothiocyanate-labelled LPS (FITC-LPS) and LIPOFECTAMINE.
- Confocal scanning laser microscopy for visualizing FITC-LPS localization.
- Cell viability assays and Western blot analysis for c-fos expression to assess toxicity.
Main Results:
- LIPOFECTAMINE facilitated significant uptake of FITC-LPS into HeLa cell cytoplasm.
- LPS loading did not induce apoptosis or alter c-fos expression.
- Acute toxicity was minimal, primarily attributed to LIPOFECTAMINE itself.
Conclusions:
- Polycationic lipid-mediated LPS loading is an effective method for intracellular studies.
- This technique allows for the investigation of acute LPS actions within mammalian cells.
- The method demonstrates low toxicity, supporting its utility in cellular research.